(Q29614601)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

author name string

Yu H

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

Jove R

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

February 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

volume

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

issue

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

30 April 2017

page(s)

97-105

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

The molecular genetics of cancer

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The multistep nature of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Rules for making human tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The phosphoinositide 3-kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Transcription factors as targets for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The pathway to signal achievement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STATs and gene regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The role of STATs in transcriptional control and their impact on cellular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

How cells respond to interferons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Protein tyrosine kinase inhibitors as novel therapeutic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Mechanism-based target identification and drug discovery in cancer research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Gp130 and the interleukin-6 family of cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The Stat family in cytokine signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stats: transcriptional control and biological impact

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Oncogenic kinase signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Role of Src expression and activation in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

JAK-STAT signaling activated by Abl oncogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT signaling in the pathogenesis and treatment of leukemias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat3 activation is required for cellular transformation by v-src

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat3 activation by Src induces specific gene regulation and is required for cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT signaling in head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

StAT signaling in cancer: insights into pathogenesis and treatment strategies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT proteins: novel molecular targets for cancer drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

c-Myc target genes involved in cell growth, apoptosis, and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Mechanisms of apoptosis by c-Myc

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

31 March 2020

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Compromised HOXA5 function can limit p53 expression in human breast tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

What Is the Evidence That Tumors Are Angiogenesis Dependent?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Oncogenes and angiogenesis: signaling three-dimensional tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

VEGFs, receptors and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Targeting HIF-1 for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

VEGF differentially activates STAT3 in microvascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Spinning molecular immunology into successful immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Does the immune system see tumors as foreign or self?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

A critical role for Stat3 signaling in immune tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Roles of STAT3 defined by tissue-specific gene targeting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat5a is mandatory for adult mammary gland development and lactogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

The role of STATs in apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Negative regulation of the JAK/STAT pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Negative regulation of cytokine signaling: STAT-induced STAT inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Modulation of STAT signaling by STAT-interacting proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC1275

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14964307

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

321642

Dimensions Publication ID

1031068002

0 references

OpenCitations bibliographic resource ID

321642

1 reference